Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Demyelinating disorders
ADR ID BADD_A01193
ADR Hierarchy
17      Nervous system disorders
17.16      Demyelinating disorders
Description Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system. | The first region-restricted episode of CNS inflammatory demyelination in a patient. It is usually characterized by an acute monosymptomatic presentation of the optic nerves, brainstem, or spinal cord. It may not reoccur (isolated), or it may progress to MULTIPLE SCLEROSIS. [MeSH]
MedDRA Code 10012303
MeSH ID D003711
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Demyelinating Diseases | Demyelinating Disease | Demyelinating Disorders | Demyelinating Disorder | Demyelination | Demyelinations | Clinically Isolated Syndrome, CNS Demyelinating | Clinically Isolated CNS Demyelinating Syndrome
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug Name
BADD_D01508Mycophenolic acid
BADD_D01549Nelarabine
BADD_D01567Nilotinib
BADD_D01580Nitrous oxide
BADD_D01596Ofatumumab
BADD_D01629Osimertinib
BADD_D01637Oxcarbazepine
BADD_D01645Oxycodone
BADD_D01653Paclitaxel
BADD_D01654Palbociclib
BADD_D01798Pomalidomide
BADD_D01834Prednisone
BADD_D01835Pregabalin
BADD_D01905Raltegravir
BADD_D01915Ranolazine
BADD_D01953Rituximab
BADD_D01954Rivaroxaban
BADD_D01989Saquinavir mesylate
BADD_D02010Sertraline
BADD_D02018Sildenafil
BADD_D02026Simvastatin
BADD_D02028Sirolimus
BADD_D02047Sodium oxybate
BADD_D02093Sulfasalazine
BADD_D02095Sulfur colloid
BADD_D02100Sunitinib
BADD_D02105Tacrolimus
BADD_D02106Tadalafil
BADD_D02160Terbinafine
BADD_D02165Teriflunomide
The 4th Page    First    Pre   4 5    Next   Last    Total 5 Pages